We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$79.7B
AUM Growth
+$3.42B
(+4.5%)
Cap. Flow
-$854M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
1,817
New
122
Increased
851
Reduced
711
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$281M |
| 2 |
Comcast
CMCSA
|
+$235M |
| 3 |
Apple
AAPL
|
+$172M |
| 4 |
MetLife
MET
|
+$151M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$399M |
| 2 |
UBS Group
UBS
|
+$393M |
| 3 |
Televisa
TV
|
+$305M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$278M |
| 5 |
New Oriental
EDU
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.42% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Technology | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1601
DELISTED
Veradigm Inc. Common Stock
MDRX
| $229K | ﹤0.01% |
17,415
+1,716
| +11% | +$22.9K |
|
|
NXGN
1602
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $229K | ﹤0.01% |
20,215
+962
| +5% | +$11.6K |
|
1603
Vera Bradley
VRA
$105M
| $227K | ﹤0.01% |
14,951
-700
| -4% | -$10.5K |
|
1604
Harte-Hanks
HHS
| $226K | ﹤0.01% |
13,935
-7,916
| -36% | -$130K |
|
1605
Trex
TREX
$4.51B
| $225K | ﹤0.01% |
15,304
-4,336
| -22% | -$60.5K |
|
|
LFC
1606
DELISTED
China Life Insurance Company Ltd.
LFC
| $224K | ﹤0.01% |
17,139
-3,486
| -17% | -$42K |
|
|
TIVO
1607
DELISTED
Tivo Inc
TIVO
| $223K | ﹤0.01% |
11,457
-3,896
| -25% | -$77K |
|
|
HR
1608
DELISTED
Healthcare Realty Trust Incorporated
HR
| $223K | ﹤0.01% |
6,550
+772
| +13% | +$27.1K |
|
1609
Iridium Communications
IRDM
$4.85B
| $222K | ﹤0.01% |
27,358
+4,133
| +18% | +$34.7K |
|
1610
Black Hills Corp
BKH
$5.73B
| $221K | ﹤0.01% |
3,607
+437
| +14% | +$26.6K |
|
|
INN
1611
Summit Hotel Properties
INN
$761M
| $221K | ﹤0.01% |
16,814
-1,932
| -10% | -$26.7K |
|
1612
Primerica
PRI
$9.81B
| $221K | ﹤0.01% |
4,164
+450
| +12% | +$24.9K |
|
1613
National Fuel Gas
NFG
$7.84B
| $220K | ﹤0.01% |
4,078
+110
| +3% | +$6.22K |
|
1614
Walker & Dunlop
WD
$1.65B
| $220K | ﹤0.01% |
+8,693
| New | +$221K |
|
|
LCI
1615
DELISTED
Lannett Company, Inc.
LCI
| $220K | ﹤0.01% |
2,067
-357
| -15% | -$43.6K |
|
|
TXNM
1616
TXNM Energy Inc
TXNM
$6.47B
| $219K | ﹤0.01% |
6,689
+429
| +7% | +$14.3K |
|
|
NILE
1617
DELISTED
Blue Nile, Inc.
NILE
| $219K | ﹤0.01% |
6,366
-2,399
| -27% | -$76.9K |
|
1618
Hanmi Financial
HAFC
$943M
| $218K | ﹤0.01% |
+8,276
| New | +$208K |
|
|
FMBI
1619
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $217K | ﹤0.01% |
11,192
-67
| -0.6% | -$1.27K |
|
|
ADPT
1620
DELISTED
Adeptus Health Inc
ADPT
| $217K | ﹤0.01% |
+5,031
| New | +$227K |
|
|
PGEM
1621
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $217K | ﹤0.01% |
+16,225
| New | +$234K |
|
1622
American Coastal Insurance
ACIC
$498M
| $216K | ﹤0.01% |
12,747
+2,248
| +21% | +$35.6K |
|
1623
American States Water
AWR
$3.39B
| $216K | ﹤0.01% |
5,402
+87
| +2% | +$3.6K |
|
|
EV
1624
DELISTED
Eaton Vance Corp.
EV
| $215K | ﹤0.01% |
5,511
-260
| -5% | -$9.95K |
|
1625
SEI Investments
SEIC
$11.9B
| $214K | ﹤0.01% |
+4,687
| New | +$220K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2016 Portfolio in Review
As of Q3 2016, OppenheimerFunds held 1,817 positions worth $79.7B, up 4.5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q3 2016 filing shows 122 new, 851 increased, 711 reduced and 96 closed positions. Its largest new stake was Fomento Económico Mexicano: 1,462,419 shares worth $135M. The largest sale was Bristol-Myers Squibb, an estimated $399M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q3 2016 buy was Fomento Económico Mexicano: 1,462,419 shares worth $135M.
- OppenheimerFunds added most to Johnson Controls International in Q3 2016, an estimated $281M increase.
- OppenheimerFunds's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $399M.
- OppenheimerFunds fully exited UBS Group in Q3 2016, selling an estimated $393M.
- OppenheimerFunds's ten largest holdings make up 14% of its $79.7B portfolio in Q3 2016.
- OppenheimerFunds opened 122 new positions and closed 96 in Q3 2016.
- OppenheimerFunds's portfolio value rose 4.5% quarter-over-quarter to $79.7B.
Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.